ClearPoint Neuro (CLPT) Price/OCF Ratio: History & Chart

ClearPoint Neuro, Inc.(CLPT)

Medical - Devices · Solana Beach, CA

$10.66-0.86 (-7.44%)

Delayed quote: Oct 6, 2026, 1:35 PM EDT

About ClearPoint Neuro, Inc.

ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.

Solana Beach, CA

172 employees

www.clearpointneuro.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Joseph Michael Burnett

View full financials

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
ClearPoint Neuro, Inc. (CLPT)	$319.77M	N/A	N/A	N/A	N/A
Cabaletta Bio, Inc. (CABA)vs ›	$319.59M	N/A	N/A	N/A	N/A
Avita Medical Inc. (RCEL)vs ›	$318.73M	N/A	N/A	N/A	N/A
Sanara MedTech Inc. (SMTI)vs ›	$321.51M	56.46	45.71	49.73	49.73
CapsoVision, Inc. (CV)vs ›	$323.26M	N/A	N/A	N/A	N/A
Agenus Inc. (AGEN)vs ›	$324.81M	N/A	418.54	418.54	418.54
C4 Therapeutics, Inc. (CCCC)vs ›	$312.90M	N/A	N/A	N/A	N/A
Mobia Medical, Inc. Common Stock (MOBI)vs ›	$303.76M	N/A	N/A	N/A	N/A
Benitec Biopharma Inc. (BNTC)vs ›	$302.21M	N/A	N/A	N/A	N/A
Relmada Therapeutics, Inc. (RLMD)vs ›	$348.35M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/OCF RATIO

TTM

ClearPoint Neuro, Inc. (CLPT)

$319.77M

N/A

Cabaletta Bio, Inc. (CABA)vs ›

$319.59M

N/A

Avita Medical Inc. (RCEL)vs ›

$318.73M

N/A

Sanara MedTech Inc. (SMTI)vs ›

$321.51M

56.46

45.71

49.73

CapsoVision, Inc. (CV)vs ›

$323.26M

N/A

Agenus Inc. (AGEN)vs ›

$324.81M

N/A

418.54

C4 Therapeutics, Inc. (CCCC)vs ›

$312.90M

N/A

Mobia Medical, Inc. Common Stock (MOBI)vs ›

$303.76M

N/A

Benitec Biopharma Inc. (BNTC)vs ›

$302.21M

N/A

Relmada Therapeutics, Inc. (RLMD)vs ›

$348.35M

N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Price/OCF Ratio: N/A

CLPT Price/OCF Ratio Metrics

CLPT Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics